L Bartošíková
University of Veterinary and Pharmaceutical Sciences Brno
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by L Bartošíková.
PLOS ONE | 2015
Eva Gabrielová; Aleksey Vladimirovich Zholobenko; L Bartošíková; J Nečas; Martin Modriansky
2,3-dehydrosilybin (DHS) is a minor flavonolignan component of Silybum marianum seed extract known for its hepatoprotective activity. Recently we identified DHS as a potentially cardioprotective substance during hypoxia/reoxygenation in isolated neonatal rat cardiomyocytes. This is the first report of positive inotropic effect of DHS on perfused adult rat heart. When applied to perfused adult rat heart, DHS caused a dose-dependent inotropic effect resembling that of catecholamines. The effect was apparent with DHS concentration as low as 10 nM. Suspecting direct interaction with β-adrenergic receptors, we tested whether DHS can trigger β agonist-dependent gene transcription in a model cell line. While DHS alone was unable to trigger β agonist-dependent gene transcription, it enhanced the effect of isoproterenol, a known unspecific β agonist. Further tests confirmed that DHS could not induce cAMP accumulation in isolated neonatal rat cardiomyocytes even though high concentrations (≥ 10 μM) of DHS were capable of decreasing phosphodiesterase activity. Pre-treatment of rats with reserpine, an indole alkaloid which depletes catecholamines from peripheral sympathetic nerve endings, abolished the DHS inotropic effect in perfused hearts. Our data suggest that DHS causes the inotropic effect without acting as a β agonist. Hence we identify DHS as a novel inotropic agent.
Interdisciplinary Toxicology | 2010
L Bartošíková; J Nečas; Tomáš Bartošík; Martin Pavlík; P Fráňa
Effect of pomiferin administration on kidney ischaemia-reperfusion injury in rats The aim of the study was to analyse protective effects of different doses of pomiferin in therapy of reperfusion injury. Rats were randomly divided into five groups (n=10). One group was intact. Three medicated groups and one placebo group were subjected to ischaemia and reperfusion of the left kidney. Pomiferin was administrated by single gastric gavage in 2 ml of 0.5% Avicel solution in doses of 5, 10 and 20 mg/kg. The placebo group was given only Avicel solution. On day 15, all the animals were exsanguinated and the reperfused kidneys were recovered. Selected biochemical markers were assessed in blood: antioxidative enzymes, total antioxidative capacity, malondialdehyde, creatinine, urea and uric acid. Creatinine, urea and total proteins were analysed in urine and 24-hour diuresis was recorded. The kidney tissue samples were used for histopathological examination. The results confirmed the expected protective effects of pomiferin. Pomiferin supported defensive reactions of the body against free radicals (increased levels of superoxide dismutase, total antioxidative capacity), decreased lipid peroxidation (decreased malondialdehyde) and contributed to the recovery of kidney functions (creatinine and urea in blood). The best biochemical and histopathological results were achieved after pomiferin administration in the dose of 5 mg/kg.
Acta Veterinaria Brno | 2005
E. M. B. El Naggar; L Bartošíková; Milan Žemlička; Emil Švajdlenka; M. Rabišková; V. Strnadová; Jiri Necas
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia | 2006
Tomáš Florian; Jiri Necas; L Bartošíková; Jarmila Klusáková; Vaclav Suchy; ElMoataz B. El Naggar; Eva Janoštíková; Tomáš Bartošík
Acta Veterinaria Brno | 2003
L Bartošíková; J Nečas; V. Suchý; R. Kubínová; D. Veselá; L. Beneš; Tomáš Bartošík; J. Illek; J. Šalplachta; Jarmila Klusáková; L. Bartošová; V. Strnadová; P. Fráňa; J. Fráňová
Acta Veterinaria Brno | 2003
L Bartošíková; J Nečas; V. Suchý; R. Kubínová; D. Veselá; L. Beneš; J. Illek; J. Šalplachta; Tomáš Florian; Marek Frydrych; Jarmila Klusáková; Tomáš Bartošík; L. Fráňa; P. Fráňa; J. Dzúrová
Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia | 2008
L Bartošíková; Jiri Necas; Tomáš Bartošík; Petr Frana; Martin Pavlík
Acta Veterinaria Brno | 2005
Eva Janoštíková; L Bartošíková; J Nečas; Jan Juřica; Tomáš Florian; Tomáš Bartošík; Jarmila Klusáková; Václav Suchý; Margita Lišková; Marek Frydrych
Acta Veterinaria Brno | 2006
Ladislava Bartošová; Marek Frydrych; G. Vaculová; Klára Beránková; Markéta Bébarová; Radka Opatřilová; V. Strnadová; P. Mokrý; V. Brunclík; J. Kolevská; Josef Krčmář; L Bartošíková; Tomáš Florian; Jiri Necas
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia | 2005
Jiri Necas; L Bartošíková; Ludek Benes; Eva Janoštíková; Tomáš Bartošík; Jarmila Klusáková; Tomáš Florian; Marek Frydrych; Jan Jurica
Collaboration
Dive into the L Bartošíková's collaboration.
University of Veterinary and Pharmaceutical Sciences Brno
View shared research outputsUniversity of Veterinary and Pharmaceutical Sciences Brno
View shared research outputsUniversity of Veterinary and Pharmaceutical Sciences Brno
View shared research outputsUniversity of Veterinary and Pharmaceutical Sciences Brno
View shared research outputs